🇺🇸 FDA
Patent

US 6852743

Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof

expired A61KA61K31/00A61K31/4188

Quick answer

US patent 6852743 (Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/00, A61K31/4188, A61K31/4245, A61P